Cheryl Cohen

Cheryl Cohen is a declared insider at 3 companies (senior executive); the most frequent names are ImmunityBio, Inc., Whitehawk Therapeutics, Inc. and Immunic, Inc. We count 13 filings; the first trade dates from 12 September 2018 and the latest from 2 October 2026.

On the market, this insider has only sold: 8 sales, €2.7M in total. The rest of the record consists of 3 share grants and 2 option exercises. So far in 2026, the count stands at no purchases and 2 sales.

The newest entry dates from 6 October 2026: an option exercise of €148k, in ImmunityBio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.